Moderna confirms COVID sales guidance as shares sink on Pfizer news
Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain
Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says.
By Ben Glickman Pfizer said it would reverse $4.2 billion in revenue after revising its agreement with the U.S. government related to its Covid-19 treatment...
The deal covering about 85,000 unionized workers offer raises and promises of increased staffing after historic worker walkout, but the details must still be ratified by union members.
The maternal RSV vaccine will significantly reduce infant hospitalizations and curb medical costs, finds a new modeling study exploring the benefit of widespread use.